Midazolam injection
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- SPE2DP26D0007
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- SPE2DP26D0007
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Jerusalem Jerusalem Israel
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical Supply Chain has awarded a sole-source contract to Rafa Laboratories Ltd. for the manufacture and delivery of Midazolam Injection CIV, 10mg/0.7mL Auto-injectors under contract SPE2DP26D0007, awarded September 22, 2026.
Rafa Laboratories is the sole FDA-approved manufacturer of this auto-injector device, which obtained approval in August 2022. The product is essential for rapid administration of anti-seizure medication in chemical, biological, radiological, or nuclear environments and requires self-administration capability by trained soldiers or companion soldiers as a life-saving measure. The statutory authority is 10 U.S.C. 3204(a)(1), implemented under FAR 6.302-1 (only one responsible source). A Sources Sought Notice issued April 28, 2025 and closed May 28, 2025 received three market research survey responses confirming Rafa Laboratories as the only known capable source.
The contract is structured as a Firm Fixed Price Indefinite Delivery/Indefinite Quantity award with a one-year base term and four one-year option periods. Quantities range from a minimum of 135,000 units to an estimated 234,240 units, with a maximum of 732,480 units. The dollar value is redacted. The contracting officer determined anticipated costs are fair and reasonable based on price analysis per FAR 15.404-1(b). The justification was approved by Matthew R. Beebe (Senior Procurement Executive) on September 8, 2025.
Notice text
In accordance with FAR 6.305(a), please see attachment for the redacted justification and approval for contract award to Rafa Laboratories Ltd. for the manufacture and delivery of Midazolam Auto-injectors.
Awarded contract SPE2DP26D0007 to unknown vendor for unknown amount on 2026-09-22.
Files
| File | Type | Posted |
|---|---|---|
| 25R0007_Midazolam_JA_REDACTED.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Limited / Sole Source Justification | |
| Midazolam injection | Award Notice |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Epinephrine Injector | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity